PTGS2 and esophageal cancer: We tested this hypothesis in a ZD:Cox-2−/− mouse oral-esophageal cancer model that mimics pharmacologic COX-2 blockade, using techniques that included transcriptome profiling, bioinformatics analyses, and investigation of the pathobiological roles of identified markers in murine tongue/forestomach preneoplasia and neoplasia.